메뉴 건너뛰기




Volumn 112, Issue 4, 2009, Pages 294-302

Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure

Author keywords

Gene expression; Heart failure; Myocyte hypertrophy; Ventricular remodeling

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MESSENGER RNA; METOPROLOL SUCCINATE;

EID: 52849102238     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000159123     Document Type: Article
Times cited : (17)

References (39)
  • 1
    • 33144483487 scopus 로고    scopus 로고
    • Executive summary: HFSA 2006, comprehensive heart failure practice guidelines
    • Adams KF, Lindenfeld J, Arnold JMO: Executive summary: HFSA 2006, comprehensive heart failure practice guidelines. J Card Fail 2006;12:10-38.
    • (2006) J Card Fail , vol.12 , pp. 10-38
    • Adams, K.F.1    Lindenfeld, J.2    Arnold, J.M.O.3
  • 2
    • 28744446343 scopus 로고    scopus 로고
    • Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure, developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-235
    • Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-235.
  • 4
    • 33644850929 scopus 로고    scopus 로고
    • Drugs for left ventricular remodeling in heart failure
    • Frigerio M, Roubina E: Drugs for left ventricular remodeling in heart failure. Am J Cardiol 2005;96:10L-18L.
    • (2005) Am J Cardiol , vol.96
    • Frigerio, M.1    Roubina, E.2
  • 6
    • 4043137474 scopus 로고    scopus 로고
    • Pharmacodynamics of β-blockers in heart failure: Lessons from the carvedilol or metoprolol European trial
    • Bauman JL, Talbert RL: Pharmacodynamics of β-blockers in heart failure: lessons from the carvedilol or metoprolol European trial. J Cardiovasc Pharmacol Ther 2004;9:117-128.
    • (2004) J Cardiovasc Pharmacol Ther , vol.9 , pp. 117-128
    • Bauman, J.L.1    Talbert, R.L.2
  • 7
    • 8444238556 scopus 로고    scopus 로고
    • β-Blockers in heart failure: Are pharmacological differences clinically important?
    • Metra M, Dei Cas L, Poole-Wilson P: β-Blockers in heart failure: are pharmacological differences clinically important? Heart Fail Rev 2004;9:131-137.
    • (2004) Heart Fail Rev , vol.9 , pp. 131-137
    • Metra, M.1    Dei Cas, L.2    Poole-Wilson, P.3
  • 8
    • 0347423198 scopus 로고    scopus 로고
    • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
    • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
  • 9
    • 0037221387 scopus 로고    scopus 로고
    • Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV: ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-168.
    • Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV: ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-168.
  • 10
    • 0344806945 scopus 로고    scopus 로고
    • Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J: The Euroheart failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2. Treatment. Eur Heart J 2003;24:464-474.
    • Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J: The Euroheart failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2. Treatment. Eur Heart J 2003;24:464-474.
  • 11
    • 0032547328 scopus 로고    scopus 로고
    • National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project
    • Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA: National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 1998;280:623-629.
    • (1998) JAMA , vol.280 , pp. 623-629
    • Krumholz, H.M.1    Radford, M.J.2    Wang, Y.3    Chen, J.4    Heiat, A.5    Marciniak, T.A.6
  • 12
    • 0034760969 scopus 로고    scopus 로고
    • Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction
    • Hulsmann M, Sturm B, Pacher R, Berger R, Bojic A, Frey B, Stanek B: Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction. J Heart Lung Transplant 2001;20:1174-1180.
    • (2001) J Heart Lung Transplant , vol.20 , pp. 1174-1180
    • Hulsmann, M.1    Sturm, B.2    Pacher, R.3    Berger, R.4    Bojic, A.5    Frey, B.6    Stanek, B.7
  • 14
    • 0030094440 scopus 로고    scopus 로고
    • Medium-term effects of beta-blockade on left ventricular mechanics: A double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction
    • Rousseau MF, Chapelle F, Van Eyll C, Stoleru L, Hager D, Van Nueten L, Pouleur H: Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction. J Card Fail 1996;2:15-23.
    • (1996) J Card Fail , vol.2 , pp. 15-23
    • Rousseau, M.F.1    Chapelle, F.2    Van Eyll, C.3    Stoleru, L.4    Hager, D.5    Van Nueten, L.6    Pouleur, H.7
  • 15
    • 0034534141 scopus 로고    scopus 로고
    • Effect of β1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril
    • Sturm B, Pacher R, Strametz-Juranek J, Berger R, Frey B, Stanek B: Effect of β1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril. Eur J Heart Fail 2000;2:407-412.
    • (2000) Eur J Heart Fail , vol.2 , pp. 407-412
    • Sturm, B.1    Pacher, R.2    Strametz-Juranek, J.3    Berger, R.4    Frey, B.5    Stanek, B.6
  • 18
    • 16844378356 scopus 로고
    • Pressure measurements
    • Grossman W, Baim DS eds, Philadelphia, Williams & Wilkins
    • Grossman W: Pressure measurements; in Grossman W, Baim DS (eds): Cardiac Catheterization, Angiography, and Intervention. Philadelphia, Williams & Wilkins, 1991, p 123.
    • (1991) Cardiac Catheterization, Angiography, and Intervention , pp. 123
    • Grossman, W.1
  • 19
    • 0017169580 scopus 로고
    • Hemodynamic determinants of the time-course of fall in canine left ventricular pressure
    • Weiss JL, Frederiksen JW, Weisfeldt ML: Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 1976;58:751-760.
    • (1976) J Clin Invest , vol.58 , pp. 751-760
    • Weiss, J.L.1    Frederiksen, J.W.2    Weisfeldt, M.L.3
  • 20
    • 0031003230 scopus 로고    scopus 로고
    • Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: Role of kinins and angiotensin II type 2 receptors
    • Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA: Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997;99:1926-1935.
    • (1997) J Clin Invest , vol.99 , pp. 1926-1935
    • Liu, Y.H.1    Yang, X.P.2    Sharov, V.G.3    Nass, O.4    Sabbah, H.N.5    Peterson, E.6    Carretero, O.A.7
  • 21
    • 0034680367 scopus 로고    scopus 로고
    • Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure
    • Sabbah HN, Stanley WC, Sharov VG, Mishima T, Tanimura M, Benedict CR, Hegde S, Goldstein S: Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. Circulation 2000;102:1990-1995.
    • (2000) Circulation , vol.102 , pp. 1990-1995
    • Sabbah, H.N.1    Stanley, W.C.2    Sharov, V.G.3    Mishima, T.4    Tanimura, M.5    Benedict, C.R.6    Hegde, S.7    Goldstein, S.8
  • 22
    • 46349099925 scopus 로고    scopus 로고
    • Effects of chronic therapy with cardiac contractility modulation electrical signals on cytoskeletal proteins and matrix metalloproteinases in dogs with heart failure
    • Rastogi S, Mishra S, Zacà V, Mika Y, Rousso B, Sabbah HN: Effects of chronic therapy with cardiac contractility modulation electrical signals on cytoskeletal proteins and matrix metalloproteinases in dogs with heart failure. Cardiology 2007;110:230-237.
    • (2007) Cardiology , vol.110 , pp. 230-237
    • Rastogi, S.1    Mishra, S.2    Zacà, V.3    Mika, Y.4    Rousso, B.5    Sabbah, H.N.6
  • 23
    • 0025884940 scopus 로고
    • Selective gene expression in failing human heart: Quantification of steady-state levels of messenger rna in endomyocardial biopsies using the polymerase chain reaction
    • Feldman AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR: Selective gene expression in failing human heart: quantification of steady-state levels of messenger rna in endomyocardial biopsies using the polymerase chain reaction. Circulation 1991;83:1866-1872.
    • (1991) Circulation , vol.83 , pp. 1866-1872
    • Feldman, A.M.1    Ray, P.E.2    Silan, C.M.3    Mercer, J.A.4    Minobe, W.5    Bristow, M.R.6
  • 24
    • 8444248625 scopus 로고    scopus 로고
    • Biologic rationale for the use of β-blockers in the treatment of heart failure
    • Sabbah HN: Biologic rationale for the use of β-blockers in the treatment of heart failure. Heart Fail Rev 2004;9:91-97.
    • (2004) Heart Fail Rev , vol.9 , pp. 91-97
    • Sabbah, H.N.1
  • 25
    • 7044241107 scopus 로고    scopus 로고
    • Cardiovascular drug class specificity: β-blockers
    • Reiter MJ: Cardiovascular drug class specificity: β-blockers. Prog Cardiovasc Dis 2004;47:11-33.
    • (2004) Prog Cardiovasc Dis , vol.47 , pp. 11-33
    • Reiter, M.J.1
  • 26
    • 0032032938 scopus 로고    scopus 로고
    • Long-term effects of β-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: Importance of timing of treatment and infarct size
    • Hu K, Gaudron P, Ertl G: Long-term effects of β-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: Importance of timing of treatment and infarct size. J Am Coll Cardiol 1998;31:692-700.
    • (1998) J Am Coll Cardiol , vol.31 , pp. 692-700
    • Hu, K.1    Gaudron, P.2    Ertl, G.3
  • 28
    • 0034647045 scopus 로고    scopus 로고
    • β-Blockade prevents sustained metalloproteinase activation and diastolic stiffening induced by angiotensin II combined with evolving cardiac dysfunction
    • Senzaki H, Paolocci N, Gluzband YA, Lindsey ML, Janicki JS, Crow MT, Kass DA: β-Blockade prevents sustained metalloproteinase activation and diastolic stiffening induced by angiotensin II combined with evolving cardiac dysfunction. Circ Res 2000;86:807-815.
    • (2000) Circ Res , vol.86 , pp. 807-815
    • Senzaki, H.1    Paolocci, N.2    Gluzband, Y.A.3    Lindsey, M.L.4    Janicki, J.S.5    Crow, M.T.6    Kass, D.A.7
  • 30
    • 0031437960 scopus 로고    scopus 로고
    • Treatment with β-blockers - the value of an even plasma concentration over 24 h
    • Agewall S, Kendall M: Treatment with β-blockers - the value of an even plasma concentration over 24 h. J Clin Pharm Ther 1997;22:171-179.
    • (1997) J Clin Pharm Ther , vol.22 , pp. 171-179
    • Agewall, S.1    Kendall, M.2
  • 31
    • 0036174668 scopus 로고    scopus 로고
    • Comparison of the affinity of beta-blockers for two states of the β1-adrenoceptor in ferret ventricular myocardium
    • Lowe MD, Lynham JA, Grace AA, Kaumann AJ: Comparison of the affinity of beta-blockers for two states of the β1-adrenoceptor in ferret ventricular myocardium. Br J Pharmacol 2002;135:451-461.
    • (2002) Br J Pharmacol , vol.135 , pp. 451-461
    • Lowe, M.D.1    Lynham, J.A.2    Grace, A.A.3    Kaumann, A.J.4
  • 32
    • 14644421602 scopus 로고    scopus 로고
    • The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors
    • Baker JG: The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors. Br J Pharmacol 2005;144:317-322.
    • (2005) Br J Pharmacol , vol.144 , pp. 317-322
    • Baker, J.G.1
  • 33
    • 0030667973 scopus 로고    scopus 로고
    • Clinical relevance of pharmacokinetic differences between β-blockers
    • Kendall MJ: Clinical relevance of pharmacokinetic differences between β-blockers. Am J Cardiol 1997;80:15J-19J.
    • (1997) Am J Cardiol , vol.80
    • Kendall, M.J.1
  • 34
    • 0030900825 scopus 로고    scopus 로고
    • Increased survival with β-blockers: Importance of ancillary properties
    • Soriano JB, Hoes AW, Meems L, Grobbee DE: Increased survival with β-blockers: Importance of ancillary properties. Prog Cardiovasc Dis 1997;39:445-456.
    • (1997) Prog Cardiovasc Dis , vol.39 , pp. 445-456
    • Soriano, J.B.1    Hoes, A.W.2    Meems, L.3    Grobbee, D.E.4
  • 35
    • 0031896341 scopus 로고    scopus 로고
    • 1 blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction
    • 1 blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction. Heart 1998;79:153-160.
    • (1998) Heart , vol.79 , pp. 153-160
    • Kardos, A.1    Long, V.2    Bryant, J.3    Singh, J.4    Sleight, P.5    Casadei, B.6
  • 36
    • 0023902113 scopus 로고
    • Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: A comparison with atenolol
    • Blomqvist I, Westergren G, Sandberg A, Jonsson UE, Lundborg P: Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol. Eur J Clin Pharmacol 1988;33(suppl):S19-S24.
    • (1988) Eur J Clin Pharmacol , vol.33 , Issue.SUPPL.
    • Blomqvist, I.1    Westergren, G.2    Sandberg, A.3    Jonsson, U.E.4    Lundborg, P.5
  • 37
    • 0035654146 scopus 로고    scopus 로고
    • Dose-related effects of metoprolol on heart rate and pharmacokinetics in heart failure
    • Andersson B, Aberg J, Lindelow B, Tang MS, Wikstrand J: Dose-related effects of metoprolol on heart rate and pharmacokinetics in heart failure. J Card Fail 2001;7:311-317.
    • (2001) J Card Fail , vol.7 , pp. 311-317
    • Andersson, B.1    Aberg, J.2    Lindelow, B.3    Tang, M.S.4    Wikstrand, J.5
  • 38
    • 0034528975 scopus 로고    scopus 로고
    • Achieving optimal β1-blockade with metoprolol CR/Zok
    • Wikstrand J: Achieving optimal β1-blockade with metoprolol CR/Zok. Basic Res Cardiol 2000;95(suppl 1):I46-I51.
    • (2000) Basic Res Cardiol , vol.95 , Issue.SUPPL. 1
    • Wikstrand, J.1
  • 39
    • 0028261043 scopus 로고
    • Effects of long-term monotherapy with enalapril, metoprolol and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction
    • Sabbah HN, Shimoyama H, Kono T, Gupta RS, Sharov VG, Scicli G, Levine TB, Goldstein S: Effects of long-term monotherapy with enalapril, metoprolol and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 1994;89:2852-2859.
    • (1994) Circulation , vol.89 , pp. 2852-2859
    • Sabbah, H.N.1    Shimoyama, H.2    Kono, T.3    Gupta, R.S.4    Sharov, V.G.5    Scicli, G.6    Levine, T.B.7    Goldstein, S.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.